JESÚS
MILLÁN NÚÑEZ-CORTÉS
Catedrático de universidad
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (38)
2024
2023
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave
Revista Clinica Espanola, Vol. 223, Núm. 5, pp. 298-309
2022
-
Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain
AIDS, Vol. 36, Núm. 5, pp. 683-690
-
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775
-
The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
Journal of General Internal Medicine, Vol. 37, Núm. 1, pp. 168-175
-
Use of glucocorticoids megadoses in SARSCoV- 2 infection in a spanish registry: SEMICOVID- 19
PLoS ONE, Vol. 17, Núm. 1 January
-
WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales
Journal of General Internal Medicine, Vol. 37, Núm. 8, pp. 1980-1987
2021
-
Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Gender-based differences by age range in patients hospitalized with covid-19: A spanish observational cohort study
Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-21
-
Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
BMC Infectious Diseases, Vol. 21, Núm. 1
-
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model
Clinical Microbiology and Infection, Vol. 27, Núm. 12, pp. 1838-1844
2020
-
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias
Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 5, pp. 209-218
2019
-
Non-HDL cholesterol as a therapeutic goal
Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 28-33
-
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects
Clinica e Investigacion en Arteriosclerosis
-
Standards for global cardiovascular risk management arteriosclerosis
Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43
2018
-
Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration
Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 4, pp. 188-192
2017
-
Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study
American Journal of Cardiovascular Drugs, Vol. 17, Núm. 2, pp. 135-142
-
Enfermedad renal crónica y dislipidemia
Clinica e Investigacion en Arteriosclerosis
-
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease
Clinica e Investigacion en Arteriosclerosis